Cell Death Nejm Primary central nervous system (CNS) vasculitis is a rare, frequently misdiagnosed condition that affects the brain and spinal cord and is characterized by a variety of neurologic symptoms at Many patients with HIV and low CD4 white blood cell counts (22 of 51 [431%]) were given multiple tecovirimat courses, some of them intravenous, and often had poor outcomes (18 of 51 [353%]) One
Cell Death Nejm It’s a real opportunity to reinforce hope and to start getting comfortable with the word ‘cure,” said a leader of the study, which tested Opdivo and Yervoy In this randomized controlled trial, among traumatic brain injury (TBI) patients with anemia, a liberal red-cell transfusion strategy resulted in no significant difference in neurological outcomes at Data demonstrated statistically significant and clinically meaningful reduction in risk of disease progression or death with Cabometyx® Pfizer Inc (NYSE: PFE) today announced its Phase 2 study of ponsegromab, a monoclonal antibody directed against growth differentiation factor-15 (GDF-15), met its primary endpoint of change from
Cell Death Nejm Data demonstrated statistically significant and clinically meaningful reduction in risk of disease progression or death with Cabometyx® Pfizer Inc (NYSE: PFE) today announced its Phase 2 study of ponsegromab, a monoclonal antibody directed against growth differentiation factor-15 (GDF-15), met its primary endpoint of change from Data demonstrated statistically significant and clinically meaningful reduction in risk of disease progression or death with Cabometyx® (cabozantinib) versus placebo in advanced pancreatic and extra-p
Comments are closed.